Literature DB >> 16252100

Childhood microscopic polyangiitis associated with MPO-ANCA.

Amira Peco-Antic1, Branka Bonaci-Nikolic, Gordana Basta-Jovanovic, Mirjana Kostic, Jasmina Markovic-Lipkovski, Milos Nikolic, Brankica Spasojevic.   

Abstract

We reviewed the clinical, histological and serological parameters of microscopic polyangiitis (MPA) associated with antineutrophil cytoplasmic antibodies (ANCA) specific to myeloperoxidase (MPO). Six girls and one boy aged 12.0+/-2.6 years (7-15 years) met the following inclusion criteria: (1) clinical manifestations of systemic small vessel involvement; (2) histological demonstration of pauci-immune necrotizing glomerulonephritis; and (3) serological findings of increased concentration of MPO-ANCA by ELISA test. The main clinical manifestations were: influenza-like symptoms (100%), hematuria/proteinuria (100%), purpura (100%), pulmonary-renal syndrome (57%), acute renal failure (ARF) (29%), ischemic cerebral insults (29%), and necrotizing vasculitis of the skin (29%). All patients underwent renal biopsy examined by immunohistochemistry with expression of alpha-smooth muscle actin (alpha SMA) in glomerular and interstitial spaces. Patients were followed from 6 months to 5.5 years (35.4+/- 23.2 months). None of the patients died. Two of seven children who had ARF progressed to end stage renal disease; one developed chronic renal failure, and four normalized renal function. ARF and central nervous system involvement at presentation were parameters of poor renal outcome. A high score of fibro-cellular glomerular crescents was associated with worse prognosis. Early treatment enables a favorable prognosis of MPO-ANCA-associated MPA in children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252100     DOI: 10.1007/s00467-005-2063-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  48 in total

1.  Rapidly progressive crescentic glomerulonephritis.

Authors:  J Charles Jennette
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

2.  The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa.

Authors:  A Bakkaloglu; S Ozen; E Baskin; N Besbas; A Gur-Guven; O Kasapçopur; K Tinaztepe
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.

Authors:  I C Locke; B Leaker; G Cambridge
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

5.  Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients.

Authors:  Herbert A Hauer; Ingeborg M Bajema; Hans C Van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.

Authors:  O Arranz; J Ara; R Rodríguez; A Saurina; E Mirapeix; A Darnell
Journal:  J Nephrol       Date:  2000 Jan-Feb       Impact factor: 3.902

7.  CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography.

Authors:  M G Pomper; T J Miller; J H Stone; W C Tidmore; D B Hellmann
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

Review 8.  Clinical applications of antineutrophil cytoplasmic antibody testing.

Authors:  Wilhelm H Schmitt; Fokko J van der Woude
Journal:  Curr Opin Rheumatol       Date:  2004-01       Impact factor: 5.006

9.  Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.

Authors:  X Bosch; E Mirapeix; J Font; X Borrellas; R Rodríguez; A López-Soto; M Ingelmo; L Revert
Journal:  Clin Nephrol       Date:  1991-09       Impact factor: 0.975

10.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11
View more
  24 in total

1.  Refractory anemia as a presenting feature of microscopic polyangiitis: a rare vasculitis in children.

Authors:  Geetanjali Jindal; Sanjay D Cruz; R P S Punia; Ravinder Kaur
Journal:  Indian J Pediatr       Date:  2011-06-01       Impact factor: 1.967

2.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

3.  Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.

Authors:  Mazdak A Khalighi; Shihtien Wang; Kammi J Henriksen; Margret Bock; Mahima Keswani; Anthony Chang; Shane M Meehan
Journal:  Pediatr Nephrol       Date:  2015-02-12       Impact factor: 3.714

4.  Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.

Authors:  XiaoWei Li; ShaoShan Liang; ChunXia Zheng; CaiHong Zeng; HaiTao Zhang; WeiXin Hu; ZhiHong Liu
Journal:  Pediatr Nephrol       Date:  2014-07-16       Impact factor: 3.714

5.  Long- term outcome of paediatric patients with ANCA vasculitis.

Authors:  Nishkantha Arulkumaran; Susan Jawad; Stuart W Smith; Lorraine Harper; Paul Brogan; Charles D Pusey; Alan D Salama
Journal:  Pediatr Rheumatol Online J       Date:  2011-06-19       Impact factor: 3.054

6.  An 11-year-old girl with antineutrophil cytoplasmic antibody-associated glomerulonephritis identified by a school urinary screening program.

Authors:  Shuto Kanno; Yukihiko Kawasaki; Ryo Maeda; Kyohei Miyazaki; Atsushi Ono; Yuichi Suzuki; Kazuhide Suyama; Shigeo Suzuki; Mitsuaki Hosoya
Journal:  CEN Case Rep       Date:  2014-05-27

7.  The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.

Authors:  Damien G Noone; Marinka Twilt; Wesley N Hayes; Paul S Thorner; Susanne Benseler; Ronald M Laxer; Rulan S Parekh; Diane Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

8.  ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine.

Authors:  Debra Boyer; Carey C Thomson; Robyn Cohen; Devika Rao; Sharon Dell; Jonathan Rayment; Ruobing Wang; Fei J Dy; Jennifer Wambach; Jade Tam-Williams; Dawn Simon; Eric Price; Christopher M Oermann; Alvin Singh; Jordan S Rettig; Elizabeth D Duncan; Christopher D Baker; Deborah R Liptzin; Paul E Moore
Journal:  Ann Am Thorac Soc       Date:  2016-06

9.  Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.

Authors:  Anne M Kouri; Sharon P Andreoli
Journal:  Pediatr Nephrol       Date:  2016-09-27       Impact factor: 3.714

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.